94 related articles for article (PubMed ID: 19428092)
21. NTP Toxicology and Carcinogenesis Studies of t -Butyl Alcohol (CAS No. 75-65-0) in F344/N Rats and B6C3F1 Mice (Drinking Water Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 436():1-305. PubMed ID: 12595927
[TBL] [Abstract][Full Text] [Related]
22. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer].
Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161
[TBL] [Abstract][Full Text] [Related]
23. Combined effect of 5-fluorouracil and carboplatin against human gastric cancer cell lines in vitro and in vivo.
Saikawa Y; Kubota T; Kuo TH; Tanino H; Kase S; Furukawa T; Watanabe M; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1994; 14(2A):461-4. PubMed ID: 8017848
[TBL] [Abstract][Full Text] [Related]
24. Comparison between CoFactor and Leucovorin activity applied in combination with 5-fluorouracil against two human colon cancer cell lines.
Bjelogrlić SK; Srdić T; Radulović S
J BUON; 2007; 12(1):71-6. PubMed ID: 17436405
[TBL] [Abstract][Full Text] [Related]
25. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
[TBL] [Abstract][Full Text] [Related]
26. [MTT assay for detecting 5-fluorouracil chemosensitivity of human breast carcinoma cell line].
Han FX; Lin H; Ru L
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):97-9. PubMed ID: 19218124
[TBL] [Abstract][Full Text] [Related]
27. Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.
Shang D; Liu Y; Matsui Y; Ito N; Nishiyama H; Kamoto T; Ogawa O
Urology; 2008 Jun; 71(6):1220-5. PubMed ID: 18538698
[TBL] [Abstract][Full Text] [Related]
28. Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder.
Arentsen HC; Jansen CF; Hulsbergen-van de Kaa CA; Laihia JK; Pylkkänen L; Leino L; Oosterwijk E; Witjes JA
J Urol; 2012 Apr; 187(4):1445-9. PubMed ID: 22341270
[TBL] [Abstract][Full Text] [Related]
29. Effect of fleroxacin on mouse bladder carcinogenesis with N-butyl-N- (4-hydroxybutyl) nitrosamine.
Ebisuno S; Nishikawa T; Kohjimoto Y; Nishihata M; Inagaki T; Watanabe T; Ohkawa T
Urol Int; 1999; 62(3):150-4. PubMed ID: 10529665
[TBL] [Abstract][Full Text] [Related]
30. [Relationships between tumor shrinkage and peripheral blood cell changes during tumor-rejection induced by a high dose of 5-FU in C57BL/6 mice].
Li CG; Li ML; Shu XH; Liu YJ; Michael N; Qin ZH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Feb; 24(2):156-8. PubMed ID: 18237534
[TBL] [Abstract][Full Text] [Related]
31. HAMLET treatment delays bladder cancer development.
Mossberg AK; Hou Y; Svensson M; Holmqvist B; Svanborg C
J Urol; 2010 Apr; 183(4):1590-7. PubMed ID: 20172551
[TBL] [Abstract][Full Text] [Related]
32. Schedule dependent efficacy of gefitinib and docetaxel for bladder cancer.
Kassouf W; Luongo T; Brown G; Adam L; Dinney CP
J Urol; 2006 Aug; 176(2):787-92. PubMed ID: 16813948
[TBL] [Abstract][Full Text] [Related]
33. CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.
Bar-Yehuda S; Madi L; Silberman D; Gery S; Shkapenuk M; Fishman P
Neoplasia; 2005 Jan; 7(1):85-90. PubMed ID: 15720820
[TBL] [Abstract][Full Text] [Related]
34. A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma.
Levitt JM; Jian W; Lerner SP; Sonpavde G
Urol Oncol; 2013 Feb; 31(2):234-40. PubMed ID: 21723160
[TBL] [Abstract][Full Text] [Related]
35. Antitumor and antiangiogenic active dendrimer/5-fluorouracil conjugates.
Lee SM; Bala YS; Lee WK; Jo NJ; Chung I
J Biomed Mater Res A; 2013 Aug; 101(8):2306-12. PubMed ID: 23355500
[TBL] [Abstract][Full Text] [Related]
36. Anti-proliferative effects of tumor necrosis factor, gamma interferon and 5-fluorouracil on human colorectal carcinoma cell lines.
Schiller JH; Bittner G
Int J Cancer; 1990 Jul; 46(1):61-6. PubMed ID: 2114374
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor effect of angiogenesis inhibitor TNP-470 and 5-FU combined therapy on human gastric cancer xenograft.
Nishimura K; Ohno M; Chung-Kang C; Kuroda Y
Hepatogastroenterology; 2008; 55(82-83):774-8. PubMed ID: 18613452
[TBL] [Abstract][Full Text] [Related]
38. Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer.
Kamat AM; DeHaven JI; Lamm DL
Urology; 1999 Jul; 54(1):56-61. PubMed ID: 10414727
[TBL] [Abstract][Full Text] [Related]
39. Cytostatic and cytotoxic effects of 5-fluorouracil on human corneal epithelial cells and keratocytes.
Midena E; Lazzarini D; Catania AG; Moretto E; Fregona I; Parrozzani R
Cornea; 2013 Mar; 32(3):338-44. PubMed ID: 22968358
[TBL] [Abstract][Full Text] [Related]
40. Thymidine phosphorylase activity in transitional cell cancer: relation to histological parameters and chemosensitivity to fluorouracil-related drugs.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Anticancer Res; 2000; 20(6B):4315-8. PubMed ID: 11205264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
